Literature DB >> 26023568

Preventive role of Indian black pepper in animal models of Alzheimer's disease.

Lokraj Subedee1, R N Suresh2, Jayanthi Mk2, Kalabharathi Hl2, Satish Am2, Pushpa Vh2.   

Abstract

INTRODUCTION: Dementia is the clinical symptom of alzheimer's disease. Brain cholinesterase levels and behavioural changes are the markers for Alzheimer's disease and aluminium chloride is one causative agent for polymerization of tau protein and amyloid plaque formation in Alzheimer's disease. Effect of piper nigrum and its role in prevention of alzhimer's disease and symptoms are well linked in this study. AIM: To study the effect of piper nigrum for the prevention of alzheimer's associated histopathological, biochemical and behaviour changes in rat model.
MATERIALS AND METHODS: Twenty four rats were taken in this study. Their baseline behavioural parameters were noted and group was separated randomly in four. Rats were pretreated with piper nigrum and Alzheimer's disease was induced. Biochemical and histopathological changes were noted at the end of experiment.
RESULTS: There was marked decrease in cholinesterase level, amyloidal plaque formation in rats brain who were pretreated with piper nigrum. At the same time there was decrease in escape latency time (ELT) and increase in memory in piper treated rats.
CONCLUSION: Piper nigrum prove to be effective for prevention of Alzheimer's disease. This finding has to be confirmed with studies including larger population. Further research on cholinesterase inhibitors, role of flavonoids on prevention of neurodegeneration in Alzheimer's disease can be encouraged.

Entities:  

Keywords:  Amyloid plaque; Cholinesterase; Dementia; Morris water maze; Piper nigrum

Year:  2015        PMID: 26023568      PMCID: PMC4437082          DOI: 10.7860/JCDR/2015/8953.5767

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

Authors:  R T Bartus
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Authors:  C Courtney; D Farrell; R Gray; R Hills; L Lynch; E Sellwood; S Edwards; W Hardyman; J Raftery; P Crome; C Lendon; H Shaw; P Bentham
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

Review 3.  Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.

Authors:  Kenjiro Ono; Tsuyoshi Hamaguchi; Hironobu Naiki; Masahito Yamada
Journal:  Biochim Biophys Acta       Date:  2006-04-07

Review 4.  Cholinergic activity and amyloid precursor protein metabolism.

Authors:  M R Roberson; L E Harrell
Journal:  Brain Res Brain Res Rev       Date:  1997-09-30

5.  Alzheimer's disease, a multifactorial disorder seeking multitherapies.

Authors:  Khalid Iqbal; Inge Grundke-Iqbal
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

6.  Tacrine in Alzheimer's disease.

Authors:  S A Eagger; R Levy; B J Sahakian
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

7.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors:  M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal:  BMJ       Date:  1999-03-06

Review 8.  Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge.

Authors:  Michael Heinrich; Hooi Lee Teoh
Journal:  J Ethnopharmacol       Date:  2004-06       Impact factor: 4.360

9.  Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+, -ATPase and Mg2+ -ATPase activities induced by the in vitro galactosaemia.

Authors:  Stylianos Tsakiris; Kleopatra H Schulpis; Kyriakoula Marinou; Panagiotis Behrakis
Journal:  Pharmacol Res       Date:  2004-05       Impact factor: 7.658

Review 10.  Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases.

Authors:  Robert A Floyd; Kenneth Hensley
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  2 in total

Review 1.  Taming Alzheimer's disease: New perspectives, newer horizons.

Authors:  Debraj Sen; Anusree Majumder; Vijinder Arora; Neha Yadu; Ritwik Chakrabarti
Journal:  Iran J Neurol       Date:  2017-07-06

2.  Neuroprotective Effects of Black Pepper Cold-Pressed Oil on Scopolamine-Induced Oxidative Stress and Memory Impairment in Rats.

Authors:  Nada M Mostafa; Ahmed M Mostafa; Mohamed L Ashour; Sameh S Elhady
Journal:  Antioxidants (Basel)       Date:  2021-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.